Khaled M. Ziada, MD

Director, Cardiac Catheterization Laboratories
Director, Cardiovascular Interventional Fellowship Program

Clinical interests

  • Angioplasty
  • Cardiovascular Disease
  • Carotid Interventions
  • Coronary Physiology
  • Interventional Cardiology
  • Intravascular Ultrasound
  • Peripheral Interventions

Khaled M. Ziada, MD

Director, Cardiac Catheterization Laboratories
Director, Cardiovascular Interventional Fellowship Program


My name is Khaled Ziada; I received my medical degree from Cairo University, School of Medicine, Egypt. I completed internal medicine residency and general cardiovascular medicine fellowship at the Cleveland Clinic Foundation. I stayed at the Cleveland Clinic for interventional fellowship training in cardiac and vascular interventions as well as a research fellowship in intravascular ultrasound.

I am board certified by the American Board of Internal Medicine in Internal Medicine, Cardiovascular Diseases and Interventional Cardiology.

Faculty rank

Professor of Medicine
Gill Foundation Professor of Interventional Cardiology


Cairo University, School of Medicine, Cairo, Egypt

Cleveland Clinic Foundation
Cairo University Hospital, Egypt

Cardiovascular Medicine, Cleveland Clinic Foundation
Interventional Cardiology, Cleveland Clinic Foundation
Research, Intravascular Ultrasound, Cleveland Clinic Foundation

Certifications or Special training
American Board of Internal Medicine
American Board of Internal Medicine, Cardiovascular Disease
American Board of Internal Medicine, Interventional Cardiology

Cardiac Catheterization

UK Albert B. Chandler Hospital - Pavilion G
Gill Heart Institute
1000 S. Limestone
Lexington KY 40536-0602

UK HealthCare accepts many forms of insurance. See list of insurers »


Recent Publications

(Five most recent publications from PubMed via an automated list based on the provider’s ID and the University of Kentucky.)
  1. Wallace EL, Tasan E, Cook BS, Charnigo R, Abdel-Latif AK, Ziada KM.
    Long-Term Outcomes and Causes of Death in Patients With Renovascular Disease Undergoing Renal Artery Stenting.
    Angiology. 2016 Aug;67(7):657-63.
  2. Sexton TR, Wallace EL, Chen A, Charnigo RJ, Reda HK, Ziada KM, Gurley JC, Smyth SS.
    Thromboinflammatory response and predictors of outcomes in patients undergoing transcatheter aortic valve replacement.
    J Thromb Thrombolysis. 2016 Apr;41(3):384-93.
  3. Ziada KM, Abdel-Latif A, Charnigo R, Moliterno DJ.
    Safety of an abbreviated duration of dual antiplatelet therapy (≤6 months) following second-generation drug-eluting stents for coronary artery disease: A systematic review and meta-analysis of randomized trials.
    Catheter Cardiovasc Interv. 2016 Mar;87(4):722-32.
  4. Ruiz-Rodriguez E, Asfour A, Lolay G, Ziada KM, Abdel-Latif AK.
    Systematic Review and Meta-Analysis of Major Cardiovascular Outcomes for Radial Versus Femoral Access in Patients With Acute Coronary Syndrome.
    South Med J. 2016 Jan;109(1):61-76.
  5. Déry JP, Mahaffey KW, Tricoci P, White HD, Podder M, Westerhout CM, Moliterno DJ, Harrington RA, Chen E, Strony J, Van de Werf F, Ziada KM, Held C, Aylward PE, Armstrong PW, Rao SV.
    Arterial access site and outcomes in patients undergoing percutaneous coronary intervention with and without vorapaxar.
    Catheter Cardiovasc Interv. 2015 Dec 23.

View this provider on PubMed